SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A strong share-price move and rising volume have fueled speculation about a short squeeze, with traders also watching for upcoming Anktiva trial data and bladder-cancer label expansion. Some see a breakout building, while others view the swings as routine trading and note that no new company announcement has been confirmed.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

New 24-month HOPE-3 extension data for Capricors deramiocel showed slower upper-limb decline in Duchenne muscular dystrophy patients, drawing bullish interest ahead of the FDA decision. Traders see the results as supportive, but debate whether they resolve the FDAs prior statistical concerns; short-squeeze talk remains speculative.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is drawing attention amid a steep, persistent pullback ahead of its fiscal Q1 earnings report, with traders looking for results, guidance or a readiness-for-service update to provide a catalyst. Bulls point to its contracted AI data-center backlog and buy the dip, while skeptics focus on financing and dilution risks, executive compensation, and the lack of recent operational updates.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistras persistent, volatile selloff is drawing attention despite traders citing no clear new catalyst; the discussion centers on whether weakness near support is a buying opportunity or a sign of further downside. Bulls point to AI-related data-center power demand, long-term agreements and CEO buying, while skeptics question when those growth prospects will translate into results and focus on the stocks poor price action ahead of earnings.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

HUT is drawing attention after a sharp selloff that traders say is unusually severe, even as Bitcoin has risen; many report no clear company announcement behind the move. Speculation includes exposure to Poolins bankruptcy or delays to its Texas data-center project, while others point to broader sector weakness and algorithmic sellingnone of these explanations is confirmed.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

Strong second-quarter results and a higher outlook, alongside new QNX automotive design winsincluding a QNX-powered smart-camera program for a major German automakerare driving attention. Bulls point to growing royalties and backlog, while skeptics focus on volatile trading and whether the positive news can translate into sustained share-price gains.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as long-term Treasury yields climb amid persistent inflation concerns, oil-related risks and expectations that rates may stay higher or rise further; traders also point to deficits and weaker confidence in U.S. debt. Sentiment is mostly bearish, though some investors see the selloff as oversold and are accumulating, while cooler PCE readings have not convinced skeptics that yields have peaked.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Googles planned Project Suncatcher testsending AI chips into orbit to explore space-based data centersis drawing attention, with traders viewing it as a potential extension of its AI infrastructure ambitions while some question whether the concept is practical or commercially meaningful. Discussion also reflects broader interest in Gemini 4 and choppy trading in the shares.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Discussion centers on the pending REGAL Phase 3 AML analysis of galinpepimut-S (GPS), with traders focused on whether the trial has reached its 80-death threshold and when results will be disclosed. Bulls view the prolonged trial as potentially favorable, while skeptics say the blinded data do not prove GPS is working and question the extended silence.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lillys mid-stage eloraTZP combination-trial results are drawing attention, with traders highlighting greater weight loss and blood-sugar reductions than tirzepatide alone as a potential boost to its obesity and diabetes pipeline. The reaction is broadly positive, though the program still needs Phase 3 testing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VNDA This phase 3 DSWPD study enrolled only 40 patients. Small chance FDA will approve it.

StockTwits Web

Vanda Pharmaceuticals Inc

 This phase 3 DSWPD study enrolled only 40 patients. Small chance FDA will approve it.